List of Tables
Table 1. Global Human Insulin Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Insulin Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Insulin Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Insulin Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Insulin Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Insulin Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Insulin Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Insulin Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Insulin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Insulin Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Insulin Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Human Insulin Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Insulin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Insulin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Insulin Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Insulin Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Human Insulin Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Insulin Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Human Insulin Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Insulin Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Human Insulin Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Insulin Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Insulin Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Insulin Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Insulin Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Insulin Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Insulin Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Insulin Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Human Insulin Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Human Insulin Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Human Insulin Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Human Insulin Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Insulin Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Insulin Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Human Insulin Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Human Insulin Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Insulin Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Insulin Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Human Insulin Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Human Insulin Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Human Insulin Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Human Insulin Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Insulin Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Insulin Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Human Insulin Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Human Insulin Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Insulin Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Human Insulin Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Human Insulin Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Human Insulin Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Biocon Company Information
Table 86. Biocon Description and Business Overview
Table 87. Biocon Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biocon Human Insulin Drugs Product
Table 89. Biocon Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Pfizer Human Insulin Drugs Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Wockhardt Company Information
Table 96. Wockhardt Description and Business Overview
Table 97. Wockhardt Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Wockhardt Human Insulin Drugs Product
Table 99. Wockhardt Recent Developments/Updates
Table 100. Julphar Company Information
Table 101. Julphar Description and Business Overview
Table 102. Julphar Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Julphar Human Insulin Drugs Product
Table 104. Julphar Recent Developments/Updates
Table 105. Exir Company Information
Table 106. Exir Description and Business Overview
Table 107. Exir Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Exir Human Insulin Drugs Product
Table 109. Exir Recent Developments/Updates
Table 110. Sedico Company Information
Table 111. Sedico Description and Business Overview
Table 112. Sedico Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sedico Human Insulin Drugs Product
Table 114. Sedico Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Insulin Drugs Distributors List
Table 118. Human Insulin Drugs Customers List
Table 119. Human Insulin Drugs Market Trends
Table 120. Human Insulin Drugs Market Drivers
Table 121. Human Insulin Drugs Market Challenges
Table 122. Human Insulin Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Insulin Drugs
Figure 2. Global Human Insulin Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Insulin Drugs Market Share by Type: 2024 & 2031
Figure 4. Basal or Long-acting Insulins Product Picture
Figure 5. Bolus or Fast-acting Insulins Product Picture
Figure 6. Traditional Human Insulins Product Picture
Figure 7. Combination Insulins Product Picture
Figure 8. Biosimilar Insulins Product Picture
Figure 9. Global Human Insulin Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Human Insulin Drugs Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Household
Figure 13. Global Human Insulin Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Insulin Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Human Insulin Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Human Insulin Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Human Insulin Drugs Report Years Considered
Figure 18. Human Insulin Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Human Insulin Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Human Insulin Drugs Players: Market Share by Revenue in Human Insulin Drugs in 2024
Figure 21. Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Human Insulin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Human Insulin Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Human Insulin Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Human Insulin Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Human Insulin Drugs by Type (2020-2031)
Figure 57. Global Human Insulin Drugs Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Human Insulin Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Human Insulin Drugs by Application (2020-2031)
Figure 60. Global Human Insulin Drugs Price (US$/Unit) by Application (2020-2031)
Figure 61. Human Insulin Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
